Hamada, K., Omura, N., Taguchi, A., Baradaran-Heravi, A., Kotake, M., Arai, M., . . . Hayashi, Y. (2019). New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations. ACS Med Chem Lett.
Chicago Style CitationHamada, Keisuke, et al. "New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations." ACS Med Chem Lett 2019.
Cita MLAHamada, Keisuke, et al. "New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations." ACS Med Chem Lett 2019.
Atenció: Aquestes cites poden no estar 100% correctes.